NASDAQ: RPRX
Royalty Pharma PLC Stock Ownership - Who owns Royalty Pharma?

Insider buying vs selling

Have Royalty Pharma PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Henry A. FernandezDirector2024-12-311,503$24.94
$37.49kBuy
Bonnie L. BasslerDirector2024-12-311,503$24.94
$37.49kBuy
Henry A. FernandezDirector2024-09-301,342$27.93
$37.48kBuy
Bonnie L. BasslerDirector2024-09-301,342$27.93
$37.48kBuy
Bonnie L. BasslerDirector2024-06-281,399$26.80
$37.49kBuy
Henry A. FernandezDirector2024-06-281,399$26.80
$37.49kBuy
Henry A. FernandezDirector2024-03-281,240$30.23
$37.48kBuy
Bonnie L. BasslerDirector2024-03-281,240$30.23
$37.48kBuy

1 of 1

RPRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RPRX insiders and whales buy or sell their stock.

RPRX Shareholders

What type of owners hold Royalty Pharma PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Morgan Stanley6.97%41,078,163$1.29BInstitution
Adage Capital Partners GP LLC6.57%38,714,280$1.22BInsider
Vanguard Group Inc6.38%37,585,123$1.18BInstitution
Fmr LLC4.73%27,890,143$877.14MInstitution
Blackrock Inc3.79%22,301,159$701.37MInstitution
Blackrock Inc 13.79%22,301,159$701.37MInstitution
1978 Sicaf Sif Sa 1. Gg3.75%22,081,156$694.45MInsider
1978 Sicaf Sif Sa Gg3.64%21,426,170$673.85MInsider
Baillie Gifford Co2.74%16,122,491$507.05MInstitution
Viking Global Investors LP2.05%12,094,021$380.36MInstitution

1 of 3

RPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RPRX52.19%16.82%Net BuyingNet Buying
UTHR87.28%12.72%Net SellingNet Selling
SMMT6.33%93.67%Net Buying
INSM83.14%16.86%Net SellingNet Selling
INCY76.05%23.95%Net SellingNet Selling

Royalty Pharma Stock Ownership FAQ

Who owns Royalty Pharma?

Royalty Pharma (NASDAQ: RPRX) is owned by 52.19% institutional shareholders, 16.82% Royalty Pharma insiders, and 30.99% retail investors. Adage Capital Partners GP LLC is the largest individual Royalty Pharma shareholder, owning 38.71M shares representing 6.57% of the company. Adage Capital Partners GP LLC's Royalty Pharma shares are currently valued at $1.22B.

If you're new to stock investing, here's how to buy Royalty Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.